The board of directors of AstraZeneca Pharma India Limited at its Meeting held on December 14, 2022, approved the Resignation of Mr. Gagandeep Singh Bedi (DIN: 07844333) from the Office of Managing Director of the Company with effect from the closing of business hours on December 31, 2022. Reason for Resignation: Consequent to transfer to a new position within AstraZeneca Group.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6,087 INR | -1.23% | -5.50% | +10.27% |
May. 28 | Astrazeneca Pharma India's Net Profit Rises in Fiscal Q4 | MT |
May. 27 | AstraZeneca Pharma India Limited Announces Resignation of Ankush Nandra as Non-Executive Director | CI |
1st Jan change | Capi. | |
---|---|---|
+10.27% | 1.85B | |
+40.73% | 739B | |
+31.59% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+14.60% | 240B | |
+9.43% | 210B | |
-4.99% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- ASTRAZEN Stock
- News AstraZeneca Pharma India Limited
- AstraZeneca Pharma India Limited Announces Resignation of Gagandeep Singh Bedi as Managing Director, Effective December 31, 2022